Loading provider…
Loading provider…
Hematology & Oncology Physician in Daytona Beach, FL
NPI: 1306844360Primary Practice Location
HALIFAX HEALTH MEDICAL CENTER
303 N Clyde Morris Blvd, Daytona Beach, FL
Primary Employer
Hhcsi Halifax Family Health Center
halifax.org
HQ Phone
Get MD Ruby's Phone Numberphone_androidMobile
Get MD Ruby's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1998 - 2027
DC State Medical License
1999 - 2008

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
MedStart Georgetown University Hospital
Fellowship • Medical Oncology
1999 - 2002
Renaissance School of Medicine at Stony Brook University
stonybrook.edu
Medical School
Until 1996
University of Miami/Jackson Health System
Residency • Internal Medicine
1996 - 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 187 | 283 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 116 | 129 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 83 | 208 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 34 | 37 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 33 | 66 |
Authors: Joseph Meschi, Amy Krie, Zubeena Mateen, Stephen Makoni, Rabih Fahed, Irfan Vaziri, Flavio Kruter
Journal: Breast J
Publication Date: 2019-06-11
Authors: Firozvi, Kashif, Deveras, Ruby Anne E, Kessler, Craig M
Journal: Am J Hematol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Fluorouracil, PROCEDURE: Computed Tomography, DRUG: Oxaliplatin, DRUG: Leucovorin Calcium
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Patient Observation
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Fluorouracil, DRUG: Veliparib, DRUG: Irinotecan Hydrochloride, DRUG: Leucovorin Calcium